An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo

The design of targeted platinum(iv) prodrugs is a very promising approach to enhance the low selectivity of platinum(ii) drugs towards cancerous tissue in order to reduce the impact on healthy tissue and, consequently, the often severe side-effects. Herein, we report a set of mono-functionalized cis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayr, Josef, Heffeter, Petra, Groza, Diana, Galvez, Luis, Koellensperger, Gunda, Roller, Alexander, Alte, Beatrix, Haider, Melanie, Berger, Walter, Kowol, Christian R., Keppler, Bernhard K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2017
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409245/
https://www.ncbi.nlm.nih.gov/pubmed/28507680
http://dx.doi.org/10.1039/c6sc03862j

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409245/
https://www.ncbi.nlm.nih.gov/pubmed/28507680
http://dx.doi.org/10.1039/c6sc03862j

Ejemplares similares